ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



“Two-thirds tumor”: A case report on Management and outcome of Adenomatoid Odontogenic Tumor

Mishal Muhammed Haris,Dimpleja J,Zarrin Rahnuma,Anirban Biswas.



Abstract
Download PDF Cited by 1 ArticlesPost

The adenomatoid odontogenic tumor is a rare tumor of epithelial origin which is also known as 2/3rds tumor as it has a unique way of presenting most commonly in maxillae in 2/3rds of cases, about 2/3rd cases are seen in females and 2/3rd cases are associated with unerupted teeth and 2/3rd cases are seen involving canines. There have not been many cases reported in the current literature of AOT presenting itself in children under the age of 15 years as an extrafollicular variety. This case report is of a 13-year-old female diagnosed with AOT in the same "two-thirds" pattern and we plan to shed some insights briefly regarding its salient radiographic features, Histopathology, and treatment protocol undertaken. We have also included details of postoperative follow-up after a period of six months in this case report.

Key words: Extrafollicular, Adenomatoid Odontogenic tumor, Adenoameloblastoma







Bibliomed Article Statistics

27
23
30
46
21
14
38
14
15
21
33
7
R
E
A
D
S

9

21

25

128

17

13

19

10

16

20

24

3
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.